Mars Flavanol Exercise and Cognitive Function Study
Study of the Impact of a Flavanol Containing Food Product and Exercise on Cognitive Function and Brain Structure
Sponsor: Mars, Inc.
Listed as NCT01180127, this NA trial focuses on Cognitive Function and remains completed. Sponsored by Mars, Inc., it has been updated 9 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Jan 2019 — Jan 2021 [monthly]
Completed NA
Phase: PHASE2 → NA
-
Jul 2018 — Jan 2019 [monthly]
Completed PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Dec 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mars, Inc.
- New York State Psychiatric Institute
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.